Scope of the Study
Rivastigmine is used to treat confusion related to Alzheimer's disease and Parkinson's disease. It does not cure these diseases but helps to improve memory, awareness and the ability to perform daily functions. It is a tartrate salt obtained by reaction of rivastigmine with one equivalent of (R,R)-tartaric acid. It is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.
The market study is being classified, by Application (Alzheimer's Disease, Parkinson's Disease and Others) and major geographies with country level break-up.
Sigma-Aldrich (United States), Novartis International AG (Switzerland), Cayman Chemical Company (United States), Thermo Fisher Scientific (United States), Sun Pharmaceutical Industries (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Luhan Pharmachem Co. Ltd. (China), Jubilant Pharma Limited (Singapore), Sandoz Inc. (United States) and Dr. Reddy's Laboratories (India) are some of the key players profiled in the study.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Vendors will contribute to the maximum growth of Global Rivastigmine Tartrate market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Rivastigmine Tartrate market by Type, Application and Region.
On the basis of geography, the market of Rivastigmine Tartrate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increase in the prevalence of Diseases such as Alzheimer's Disease and Parkinson's Disease
- Development of New Diagnostic Centres and Hospitals
- Technological Advancements in the Field of Medical Science
- Growing Number of Regulatory Approvals
- Huge Investments and Franchising By Major Players
Market Leaders and their expansionary development strategies
In June 2019, Merck acquired US-based life science company Sigma Aldrich. Sigma Aldrich’s shareholders approved the merger with Merck at a special meeting held at the Sigma Aldrich Life Science and Technology Center.
Key Target AudienceRivastigmine Tartrate Manufacturers, Research Professionals, Emerging Companies, Distributors, Government Body & Associations and End-user
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase